Total compensation: $6,823,764 for the year ended Dec. 31
Salary: $1,097,574
Non-equity incentive pay: $1,470,612
Other compensation: $10,800
Exercised stock options: $2,945,700
Value realized on vesting shares: $1,299,078
New stock options: 322,428
Total 2014 shareholder return: 6.7 percent
Note: St. Jude Chief Executive Daniel Starks took home $6.8 million in 2014, up 84.5 percent from $3.7 million in 2013.
St. Jude Medical, which filed its definitive proxy on Wednesday, reported year-end sales of $5.7 billion and adjusted earnings of $3.98 per share. That performance helped Starks and other senior management earn annual bonuses that were 99.25 percent of target-level bonuses for the year. Starks' $1.5 million bonus was up 2.8 percent from his bonus in 2013.
Starks also got a salary increase of about 5 percent. The biggest increase to his 2014 compensation was from previously issued long-term equity awards that vested or Starks exercised last year. He exercised $2.9 million worth of options in 2014 and had $1.3 million worth of restricted shares that vested during the year, compared with $585,499 and $600,558 in 2013.
Patrick Kennedy
Some say the MAHA movement and GLP-1 drugs hurt sugar beet farmers. The White House is blaming former President Joe Biden.
